Protected: Peripheral artery disease in the UK – unmet needs

2 CPD/CME credits, 2 hours
Click any image to enlarge
Sponsorship Statement: Bayer plc. commissioned and funded this supplement. The company has reviewed the data to ensure factual accuracy in relation to Bayer products and compliance with industry guidelines. Rivaroxaban prescribing information current at the time of publication is available here.
Job code: PP-XAR-GB-1131
Date of preparation: January 2020

For notes on dosing recommendations from Xarelto® ▼ (rivaroxaban) SmPC (Summary of Product Characteristics) please see the box at the foot of this page

This content is password protected. To view it please enter your password below:

Use for revalidation – BJC Learning with reflection activity

This article can be used towards revalidation. If you would like to reflect on what you have learned, please log in or register to record your thoughts on how this article has influenced your practice.